No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr21:39848400-39858600 |
Weak transcription |
Fetal Muscle Trunk |
muscle
|
2 |
chr21:39849600-39858600 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
3 |
chr21:39852200-39858800 |
Weak transcription |
Fetal Thymus |
thymus
|
4 |
chr21:39852200-39860000 |
Weak transcription |
Spleen |
Spleen
|
5 |
chr21:39855000-39861800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
6 |
chr21:39855400-39860800 |
Enhancers |
NHEK |
skin
|
7 |
chr21:39856400-39859600 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
8 |
chr21:39856400-39862200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
9 |
chr21:39856600-39858800 |
Weak transcription |
iPS-20b Cell Line |
embryonic stem cell
|
10 |
chr21:39856800-39858600 |
Weak transcription |
Muscle Satellite Cultured Cells |
--
|
11 |
chr21:39856800-39858600 |
Enhancers |
HUVEC |
blood vessel
|
12 |
chr21:39856800-39858800 |
Weak transcription |
iPS-18 Cell Line |
embryonic stem cell
|
13 |
chr21:39857000-39860200 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
14 |
chr21:39857000-39860800 |
Weak transcription |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
15 |
chr21:39857400-39858600 |
Genic enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
16 |
chr21:39857600-39860600 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
17 |
chr21:39857600-39861800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
18 |
chr21:39857800-39860800 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
19 |
chr21:39857800-39860800 |
Enhancers |
HMEC |
breast
|
20 |
chr21:39858000-39858600 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
21 |
chr21:39858000-39859000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
22 |
chr21:39858000-39860000 |
Enhancers |
Left Ventricle |
heart
|
23 |
chr21:39858000-39860200 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
24 |
chr21:39858000-39860200 |
Enhancers |
Aorta |
Aorta
|
25 |
chr21:39858000-39860200 |
Enhancers |
Lung |
lung
|
26 |
chr21:39858000-39862400 |
Genic enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
27 |
chr21:39858000-39864000 |
Enhancers |
Fetal Heart |
heart
|
28 |
chr21:39858200-39858400 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
29 |
chr21:39858200-39858400 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
30 |
chr21:39858200-39858400 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
31 |
chr21:39858200-39858400 |
Enhancers |
Gastric |
stomach
|
32 |
chr21:39858200-39858400 |
Enhancers |
Right Ventricle |
heart
|
33 |
chr21:39858200-39858400 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
34 |
chr21:39858200-39858600 |
Enhancers |
Hela-S3 |
cervix
|
35 |
chr21:39858200-39858800 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
36 |
chr21:39858200-39858800 |
Enhancers |
Placenta |
Placenta
|
37 |
chr21:39858200-39859000 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
38 |
chr21:39858200-39859000 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
39 |
chr21:39858200-39859000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
40 |
chr21:39858200-39859000 |
Enhancers |
NH-A |
brain
|
41 |
chr21:39858200-39859000 |
Enhancers |
Osteobl |
bone
|
42 |
chr21:39858200-39859400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
43 |
chr21:39858200-39860000 |
Enhancers |
Right Atrium |
heart
|
44 |
chr21:39858200-39860800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
45 |
chr21:39858200-39861000 |
Enhancers |
Esophagus |
oesophagus
|
46 |
chr21:39858200-39861400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|